Resources
Slideshow
Pharmaceutical Executive
Beyond the Pharma 50: Key Data Trends and Highlights
Author(s):
Dive into a sampling of data drivers—and expanded insights—poised to impact and reshape our annual leaderboard.
In this special slideshow presentation, explore a selection of graphical snapshots—a metrics mashup, if you will—spotlighting a handful of the pivotal, underlying, and overpowering (think GLP-1s) drivers of Pharm Exec's yearly Pharma 50 company rankings.
Featured ahead is drilled-down data on the latest trends around pipeline costs and market return (including first-time product launchers); biotech funding; the GLP-1 Rx curve; and a glimpse into today's active oncology R&D landscape, including exclusive, quick-hit insights on six perhaps under-the-radar players in our Top 50 that are advancing efforts in the cancer space.
Newsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
